Atrás
Rango del Día
$22.97
$25.56
Rango de 52 Semanas
$2.76
$30.60
Volumen
2,057,666
Promedio 50D / 200D
$26.18
/
$10.64
Cierre Anterior
$25.06
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -11.3 | 0.4 |
| P/B | 9.1 | 2.9 |
| ROE % | -86.7 | 3.7 |
| Net Margin % | -1011.8 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Puntos Clave
Debt/Equity of 0.12 — conservative balance sheet
Negative free cash flow of -370.18M
PEG of 0.47 suggests growth is underpriced
Capital efficient — spends only 2.72% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-86.69%
ROIC-94.73%
Net Margin-1011.75%
Op. Margin-1776.32%
Seguridad
Debt / Equity
0.12
Current Ratio4.34
Interest Coverage0.00
Valoración
P/E Ratio
-11.28
P/B Ratio9.11
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 24.05M | Net Income (TTM) | -243.33M |
| ROE | -86.69% | ROA | -59.07% |
| Gross Margin | 85.46% | Operating Margin | -1776.32% |
| Net Margin | -1011.75% | Free Cash Flow (TTM) | -370.18M |
| ROIC | -94.73% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 4.34 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.28 | P/B Ratio | 9.11 |
| P/S Ratio | 114.13 | PEG Ratio | 0.47 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.74B | Enterprise Value | 2.69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 24.05M | 0.0 | 0.0 | 0.0 |
| Net Income | -243.33M | -294.23M | -154.99M | -111.93M |
| EPS (Diluted) | -2.86 | -10.38 | -2.99 | -14.93 |
| Gross Profit | 20.55M | -3.15M | 0.0 | -250,000.0 |
| Operating Income | -427.20M | -300.75M | -158.17M | -113.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 411.94M | 340.99M | 89.61M | 108.17M |
| Total Liabilities | 110.64M | 80.89M | 428.87M | 303.41M |
| Shareholders' Equity | 301.30M | 260.10M | -339.26M | -195.24M |
| Total Debt | 36.91M | 30.72M | 32.58M | 1.78M |
| Cash & Equivalents | 89.67M | 169.53M | 46.00M | 25.61M |
| Current Assets | 318.23M | 306.19M | 53.36M | 102.56M |
| Current Liabilities | 73.32M | 50.91M | 20.87M | 13.35M |